The following journal-based CME activities are made possible through a joint partnership of the journal with the Society for Vascular Medicine (SVM) and University of Virginia School of Medicine and School of Nursing.
In support of improving patient care, this activity has been planned and implemented by the Society for Vascular Medicine and the University of Virginia School of Medicine and School of Nursing and is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
The University of Virginia School of Medicine and School of Nursing designates the peer review activity for a maximum of 3.0 AMA PRA Category 1 Credits™ per review and the reading activity for a maximum of 1.0 AMA PRA Category 1 Credit.™ Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The University of Virginia School of Medicine and School of Nursing awards 3.0 hours of participation for the peer review activity and 1.0 hours of participation for the reading activity (consistent with the designated number of AMA PRA Category 1 Credit(s)™ or ANCC contact hours) to a participant who successfully completes this educational activity.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 3.0 MOC points for the peer review activity and 1.0 MOC point for the reading activity in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC II credit. UVASOM maintains a record of participation for 6 years.
AMA PRA Category 1 credit ™ (CME) and MOC II credit, from the American Board of Internal Medicine (ABIM), are available for reviewing manuscripts submitted to Vascular Medicine. Non-physician reviewers may earn hours of participation.
Please note: MOC II credit will be reported quarterly. Credit received after November 30 of each year will be applied to the following year. IMPORTANT: Your ABIM number must be in your UVASOM profile to be reported.
Reviews are rated by the Editors for quality and timeliness on a scale of 1-3. The metric for quality of review is based on the quality of comments. For example, a score of 1 = review is below average (1-2 sentences with no suggestions for the authors); 2 = review is sufficient (succinct, focused review with a few suggestions for the authors); and 3 = review is above average (comprehensive and thoughtful review with highly detailed feedback for the authors). For timeliness, a score of 1 = review was severely delayed (> 22 days); 2 = review was slightly delayed (15-21 business days); 3 = review was on time (0-14 business days). To be eligible for credit, the reviewer must receive an average composite score of at least 2.0. For example, a slightly delayed high-quality review would receive a 3 for quality and 2 for timeliness, which is 2.5 composite score.
NOTE: After the decision letter is sent to the authors, eligible reviewers will receive instructions for claiming credit in a separate email from the editorial office. The instructions will contain an activity code for the online evaluation, which must be completed to received credit. Reviewers will need to enter the manuscript ID number, manuscript title, and first author to begin the evaluation. Appropriate credit will be recorded when the online evaluation is completed.
The Vascular Medicine planning committee has no financial relationship or interest with any proprietary entity producing healthcare goods or services. See below for additional disclosure information.
AMA PRA Category 1 credit™ (CME) and MOC II credit, from the American Board of Internal Medicine (ABIM), are available for reading select articles published in Vascular Medicine. Non-physicians may earn hours of participation.
There are no fees for the credits; however, there may be a fee to download the article from the Vascular Medicine website if you do not have an active subscription or journal access.
Please note: MOC II credit is available only for articles published after January 2019. MOC II credit will be reported quarterly. Credit received after November 30 of each year will be applied to the following year. IMPORTANT: Your ABIM number must be in your UVASOM profile to be reported.
The Vascular Medicine planning committee disclosed the following: Aditya Sharma is supported by National Institute of Health Sciences, AstraZeneca, and Biomet Biologics. Heather Gornik and Valerie Clark have no financial affiliations to disclose. The author disclosures are listed at the beginning of each article. See below for additional disclosure information.
Participants are expected to download and read the article, then complete the CME evaluation and MOC post-test questions with an 80% score or higher to receive credit.
Articles Available for Credit
Expires: February 1, 2023
Raynaud’s phenomenon and related vasospastic disorders
Expires: June 1, 2022
|June 2020||Vascular effects of cancer treatment
Disclosure of faculty financial affiliations
The University of Virginia School of Medicine and School of Nursing as a Joint Accreditation Provider adhere to the ACCME Standards for Integrity and Independence in Accredited Continuing Education, released in December 2020, as well as Commonwealth of Virginia statutes, University of Virginia policies and procedures, and associated federal and private regulations and guidelines. As the accredited provider for this CE/IPCE activity, we are responsible for ensuring that healthcare professionals have access to professional development activities that are based on best practices and scientific integrity that ultimately supports the care of patients and the public.
All individuals involved in the development and delivery of content for an accredited CE/IPCE activity are expected to disclose relevant financial relationships with ineligible companies occurring within the past 24 months (such as grants or research support, employee, consultant, stock holder, member of speakers bureau, etc.). The University of Virginia School of Medicine and School of Nursing employ appropriate mechanisms to resolve potential conflicts of interest and ensure the educational design reflects content validity, scientific rigor and balance for participants. Questions about specific strategies can be directed to the University of Virginia School of Medicine and School of Nursing of the University of Virginia, Charlottesville, Virginia.
The faculty, staff and planning committee engaged in the development of this CE/IPCE activity in the Joint Accreditation CE Office of the School of Medicine and School of Nursing have no financial affiliations to disclose.
Disclosure of discussion of non-FDA approved uses for pharmaceutical products and/or medical devices
As a Joint Accreditation provider, the University of Virginia School of Medicine and School of Nursing, requires that all faculty presenters identify and disclose any off-label or experimental uses for pharmaceutical and medical device products.
It is recommended that each clinician fully review all the available data on new products or procedures prior to clinical use.